Open AccessStatins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2
Author(s) -
Keith Dadson,
Paaladinesh Thavendiranathan,
Ludger Hauck,
Daniela Grothe,
Muhammad Azam,
Shanna Stanley-Hasnain,
Donya Mahiny-Shahmohammady,
Daoyuan Si,
Mahmoud Bokhari,
Patrick F.H. Lai,
Stéphane Massé,
Kumaraswamy Nanthakumar,
Filio Billia
Publication year - 2022
Publication title -
cjc open
Language(s) - English
Resource type - Journals
ISSN - 2589-790X
DOI - 10.1016/j.cjco.2022.08.006
Subject(s) - rosuvastatin , doxorubicin , cardiotoxicity , phospholamban , medicine , cardioprotection , pharmacology , ryanodine receptor , protein kinase b , cardiac function curve , endocrinology , heart failure , chemotherapy , chemistry , ischemia , phosphorylation , calcium , biochemistry